Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
International Journal of Oncology|December 17, 2008
Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2Javier A Menendez, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.International Journal of Oncology|December 4, 2009
Serine 2481-autophosphorylation of mammalian target of rapamycin (mTOR) couples with chromosome condensation and segregation during mitosis: confocal microscopy characterization and immunohistochemical validation of PP-mTOR(Ser2481) as a novel high-contrast mitosis marker in breast cancer core biopsiesEugeni Lopez-Bonet, Alejandro Vazquez-Martin, Maria Carmen Pérez-Martínez, et al.Cell Cycle (Georgetown, Tex.)|March 4, 2011
Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181aCristina Oliveras-Ferraros, Sílvia Cufí, Alejandro Vazquez-Martin, et al.Biochemical and Biophysical Research Communications|May 18, 2010
Dynamic emergence of the mesenchymal CD44(pos)CD24(neg/low) phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin)Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Begoña Martin-Castillo, et al.Cell Cycle (Georgetown, Tex.)|February 16, 2012
Metformin rescues cell surface major histocompatibility complex class I (MHC-I) deficiency caused by oncogenic transformationCristina Oliveras-Ferraros, Sílvia Cufí, Alejandro Vazquez-Martin, et al.Oncotarget|December 29, 2011
Metformin: multi-faceted protection against cancerSonia Del Barco, Alejandro Vazquez-Martin, Sílvia Cufí, et al.BMC Cancer|May 11, 2007
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cellsJavier A Menendez, Alejandro Vazquez-Martin, Ramon Colomer, et al.Oncotarget|May 9, 2012
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenograftsSilvia Cufi, Bruna Corominas-Faja, Alejandro Vazquez-Martin, et al.Cell Cycle (Georgetown, Tex.)|January 5, 2013
The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cellsAlejandro Vazquez-Martin, Bruna Corominas-Faja, Sílvia Cufi, et al.Cell Cycle (Georgetown, Tex.)|October 26, 2012
Ser2481-autophosphorylated mTOR colocalizes with chromosomal passenger proteins during mammalian cell cytokinesisAlejandro Vazquez-Martin, Tamara Sauri-Nadal, Octavio J Menendez, et al.Pageof 8